Convergence Investment Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
202,212
+79,854
+65% +$891K 0.18% 167
2026
Q1
$1.33M Buy
+122,358
New +$1.05M 0.22% 163
2019
Q4
Sell
-8,763
Closed -$75K 298
2019
Q3
$75K Sell
8,763
-5,547
-39% -$54.4K 0.02% 292
2019
Q2
$165K Buy
+14,310
New +$184K 0.04% 275
2014
Q4
Sell
-28,104
Closed -$914K 418
2014
Q3
$914K Buy
+28,104
New +$954K 0.13% 248
2014
Q2
Sell
-8,164
Closed -$259K 411
2014
Q1
$259K Buy
+8,164
New +$227K 0.04% 314

Other funds holding PTEN

Convergence Investment Partners's PTEN Position: Q2 2026 in Review

Convergence Investment Partners increased its Patterson-UTI (PTEN) stake by 65% in Q2 2026, buying an estimated $891K and bringing the position to 202,212 shares worth $1.86M. The position accounts for 0.18% of the portfolio, ranked #167.

Convergence Investment Partners first reported a position in PTEN in Q1 2014 and has held it in 6 quarters since. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Convergence Investment Partners held 202,212 shares of Patterson-UTI worth $1.86M as of Q2 2026.
  • Convergence Investment Partners bought 79,854 Patterson-UTI shares in Q2 2026, an estimated $891K.
  • Patterson-UTI made up 0.18% of Convergence Investment Partners's portfolio in Q2 2026, its #167 holding.
  • Convergence Investment Partners first reported a position in Patterson-UTI in Q1 2014 and has held it in 6 quarters since.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.